Le Mendoza Pharmaceutical products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Karachi · Pakistan
Karachi pharmaceutical manufacturer established in 1971, producing antibiotics and general pharmaceutical dosage forms.
Le Mendoza Pharmaceutical products in Pakistan
Le Mendoza Pharmaceutical (Pvt) Ltd has 22 medicine presentations registered in Pakistan under 13 brands, covering 11 generic medicines. Most of its products are in Anti-infectives, Vitamins, minerals & nutrition and Hematology & thrombosis. Its brands with the most registered strengths and packs are Ciprocam (Ciprofloxacin), Azocam (Azithromycin), Kilcam (Clarithromycin) and Craflox (Levofloxacin). 22 products have an official DRAP price on MedInfoBase. See all 13 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Le-Mendoza Pharmaceutical (Pvt.) Limited
- Company type
- Private pharmaceutical manufacturer
- Address
- Plot No. 7, Sector 23, Korangi Industrial Area, Karachi 76500, Pakistan · 76500
- Website
- medicamgroup.com/lemendoza ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 63%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Le Mendoza Pharmaceutical (Pvt) Ltd. is priced against the market
22 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Azocam | Azithromycin | 200 mg/5 mL | Suspension | 15ml | 028183 | PKR 320.34 | PKR 21.36/mL | 🔒 Pharma Pro |
| Azocam | Azithromycin | 250 mg | Capsule | 10's | 028184 | PKR 543.62 | PKR 54.36/capsule | 🔒 Pharma Pro |
| Azocam | Azithromycin | 500 mg | Tablet | 6's | 098581 | PKR 441.57 | PKR 73.60/tablet | 🔒 Pharma Pro |
| Camfolit | Folic acid | 5 mg | Tablet | 100's | 003227 | PKR 78.76 | PKR 0.79/tablet | 🔒 Pharma Pro |
| Camotaren Injection 75mgRegistry verified | Diclofenac Sodium | — | — | — | 019719Official source ↗ | No indexed price | — | — |
| Ciprocam | Ciprofloxacin | 3 mg/mL | Ear drops | 5ml | 055658 | PKR 144.24 | PKR 28.85/mL | 🔒 Pharma Pro |
| Ciprocam | Ciprofloxacin | 125 mg/5 mL | Dry suspension | 60ml | 073695 | PKR 222.36 | PKR 3.71/mL | 🔒 Pharma Pro |
| Ciprocam | Ciprofloxacin | 250 mg/5 mL | Dry suspension | 60ml | 073696 | PKR 310.64 | PKR 5.18/mL | 🔒 Pharma Pro |
| Ciprocam | Ciprofloxacin | 250 mg | Tablet | 10's | 098582 | PKR 208.74 | PKR 20.87/tablet | 🔒 Pharma Pro |
| Ciprocam | Ciprofloxacin | 500 mg | Tablet | 10's | 098583 | PKR 345.23 | PKR 34.52/tablet | 🔒 Pharma Pro |
| Craflox | Levofloxacin | 250 mg | Tablet | 10's | 055661 | PKR 485.38 | PKR 48.54/tablet | 🔒 Pharma Pro |
| Craflox | Levofloxacin | 500 mg | Tablet | 10's | 055662 | PKR 807.66 | PKR 80.77/tablet | 🔒 Pharma Pro |
| Kilcam | Clarithromycin | 250 mg | Tablet | 10's | 050469 | PKR 465.97 | PKR 46.60/tablet | 🔒 Pharma Pro |
| Kilcam | Clarithromycin | 500 mg | Tablet | 10's | 050470 | PKR 863.96 | PKR 86.40/tablet | 🔒 Pharma Pro |
| Kilcam | Clarithromycin | 125 mg/5 mL | Dry suspension | 60ml | 055660 | PKR 432.95 | PKR 7.22/mL | 🔒 Pharma Pro |
| Kilcam Oral | Clarithromycin | 125 mg/5 mL | Oral drops | 25ml | 105533 | PKR 141.20 | PKR 5.65/mL | 🔒 Pharma Pro |
| Malagon-AL Forte | Artemether + Lumefantrine | 240 mg + 240 mg | Tablet | 8's | 058643 | PKR 512.56 | PKR 64.07/tablet | 🔒 Pharma Pro |
| Mecinin | Artemether | 80 mg | Injection | 6's | 050467 | PKR 757.18 | PKR 126.20/vial/unit | 🔒 Pharma Pro |
| Pangab 50mg CapsuleRegistry verified | Pregabalin | — | — | — | 081051Official source ↗ | No indexed price | — | — |
| Paracetamol | Paracetamol | 500 mg | Tablet | 200’s | 003226 | PKR 705.01 | PKR 3.53/tablet | 🔒 Pharma Pro |
| Transcam | Tranexamic acid | 250 mg/5 mL | Injection | 10's | 017661 | PKR 582.45 | PKR 58.25/vial/unit | 🔒 Pharma Pro |
| Transcam DS | Tranexamic acid | 500 mg/5 mL | Injection | 10's | 037526 | PKR 1,131.89 | PKR 113.19/vial/unit | 🔒 Pharma Pro |
| Vita-6 | Pyridoxine HCl | 50 mg | Tablet | 20's | 003225 | PKR 93.06 | PKR 4.65/tablet | 🔒 Pharma Pro |
| Welday | Moxifloxacin | 400 mg | Tablet | 5's | 067235 | PKR 922.21 | PKR 184.44/tablet | 🔒 Pharma Pro |
All 13 Le Mendoza Pharmaceutical brands in Pakistan
- Azocam Azithromycin · 200 mg/5 mL suspension, 250 mg capsule, 500 mg tablet
- Camfolit Folic acid · 5 mg tablet
- Ciprocam Ciprofloxacin · 125 mg/5 mL suspension, 250 mg tablet, 250 mg/5 mL suspension
- Craflox Levofloxacin · 250 mg tablet, 500 mg tablet
- Kilcam Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
- Kilcam Oral Clarithromycin · 125 mg/5 mL drops
- Malagon-AL Forte Artemether + Lumefantrine · 240 mg + 240 mg tablet
- Mecinin Artemether · 80 mg injection
- Paracetamol Paracetamol · 500 mg tablet
- Transcam Tranexamic acid · 250 mg/5 mL injection
- Transcam DS Tranexamic acid · 500 mg/5 mL injection
- Vita-6 Pyridoxine HCl · 50 mg tablet
- Welday Moxifloxacin · 400 mg tablet
Le Mendoza Pharmaceutical: common questions
How many products does Le Mendoza Pharmaceutical have in Pakistan?
Le Mendoza Pharmaceutical (Pvt) Ltd has 22 registered medicine presentations in Pakistan, sold under 13 brands and covering 11 generic medicines.
What are the main brands of Le Mendoza Pharmaceutical?
By number of registered strengths and packs, its largest brands are Ciprocam (Ciprofloxacin), Azocam (Azithromycin), Kilcam (Clarithromycin), Craflox (Levofloxacin) and Camfolit (Folic acid). This is not a sales ranking.
Which therapy areas does Le Mendoza Pharmaceutical cover?
The most products are in Anti-infectives (17), Vitamins, minerals & nutrition (2), Hematology & thrombosis (2) and Pain & musculoskeletal (1).
Where can I see Le Mendoza Pharmaceutical medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.